RJA
IBDQ

Raymond James & Associates’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Raymond James & Associates’s Portfolio IBDQ Stock Details IBDQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$17M Sell
676,600
-93,143
-12% -$2.32M 0.01% 917
2024
Q2 		$19.1M Buy
769,743
+50,579
+7% +$1.25M 0.01% 802
2024
Q1 		$17.8M Buy
719,164
+44,309
+7% +$1.1M 0.01% 829
2023
Q4 		$16.7M Buy
674,855
+200,071
+42% +$4.9M 0.01% 817
2023
Q3 		$11.6M Buy
474,784
+31,982
+7% +$780K 0.01% 961
2023
Q2 		$10.8M Sell
442,802
-6,205
-1% -$152K 0.01% 1009
2023
Q1 		$11M Buy
449,007
+29,172
+7% +$713K 0.01% 979
2022
Q4 		$10.2M Buy
419,835
+72,656
+21% +$1.76M 0.01% 986
2022
Q3 		$8.38M Sell
347,179
-37,511
-10% -$925K 0.01% 1064
2022
Q2 		$9.5M Buy
384,690
+100,982
+36% +$2.51M 0.01% 1008
2022
Q1 		$7.16M Buy
283,708
+77,141
+37% +$1.99M 0.01% 1260
2021
Q4 		$5.46M Buy
206,567
+25,902
+14% +$688K ﹤0.01% 1492
2021
Q3 		$4.85M Sell
180,665
-1,789
-1% -$48.3K ﹤0.01% 1514
2021
Q2 		$4.92M Buy
182,454
+8,316
+5% +$224K ﹤0.01% 1503
2021
Q1 		$4.67M Buy
174,138
+34,487
+25% +$934K ﹤0.01% 1465
2020
Q4 		$3.82M Buy
139,651
+9,301
+7% +$253K ﹤0.01% 1485
2020
Q3 		$3.54M Sell
130,350
-1,786
-1% -$48.5K ﹤0.01% 1410
2020
Q2 		$3.56M Sell
132,136
-7,486
-5% -$196K ﹤0.01% 1396
2020
Q1 		$3.49M Buy
139,622
+7,133
+5% +$184K 0.01% 1249
2019
Q4 		$3.44M Buy
132,489
+85,598
+183% +$2.21M ﹤0.01% 1502
2019
Q3 		$1.21M Buy
46,891
+4,834
+11% +$124K ﹤0.01% 2075
2019
Q2 		$1.08M Buy
42,057
+3,822
+10% +$95.6K ﹤0.01% 2167
2019
Q1 		$951K Buy
38,235
+1,310
+4% +$31.9K ﹤0.01% 2240
2018
Q4 		$871K Sell
36,925
-5,633
-13% -$133K ﹤0.01% 2165
2018
Q3 		$1.02M Buy
42,558
+1,918
+5% +$46K ﹤0.01% 2249
2018
Q2 		$973K Buy
40,640
+55
+0.1% +$1.32K ﹤0.01% 2234
2018
Q1 		$985K Buy
40,585
+19,231
+90% +$470K ﹤0.01% 2134
2017
Q4 		$534K Buy
21,354
+3,394
+19% +$85.1K ﹤0.01% 2497
2017
Q3 		$452K Buy
17,960
+1,374
+8% +$34.5K ﹤0.01% 2542
2017
Q2 		$414K Buy
+16,586
New +$413K ﹤0.01% 2537

Other funds holding IBDQ

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SVWAG
Sound View Wealth Advisors Group Savannah, Georgia $1.47B AUM 18.47% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Raymond James & Associates's IBDQ Position: Q3 2024 in Review

Raymond James & Associates reduced its iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) stake by 12% in Q3 2024, selling an estimated $2.32M and leaving 676,600 shares worth $17M. The position accounts for 0.01% of the portfolio, ranked #917.

Raymond James & Associates first reported a position in IBDQ in Q2 2017 and has held it in 30 quarters since. The position peaked at $19.1M in Q2 2024. 363 funds tracked by Wall St. Rank hold IBDQ as of Q3 2024.

  • Raymond James & Associates held 676,600 shares of iShares iBonds Dec 2025 Term Corporate ETF worth $17M as of Q3 2024.
  • Raymond James & Associates sold 93,143 iShares iBonds Dec 2025 Term Corporate ETF shares in Q3 2024, an estimated $2.32M.
  • iShares iBonds Dec 2025 Term Corporate ETF made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #917 holding.
  • Raymond James & Associates first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q2 2017 and has held it in 30 quarters since.
  • Raymond James & Associates's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $19.1M in Q2 2024.
  • 363 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.